Ceftrixn™
Active ingredients: Ceftriaxone
Consumer medicine information
Read the CMI leaflet (Opens in new tab) for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
Treatment of the following infections when caused by susceptible aerobic organisms:,1 Lower respiratory tract infections. Caused by Strep. pneumoniae, Streptococcus sp. (excluding Enterococci), methicillin sensitive Staph. aureus, H. influenzae, H. parainfluenzae, Klebsiella sp. (including K. pneumoniae), E. coli, E. aerogenes, P. mirabilis and Serratia marcescens.,2 Skin and skin structure infections. Caused by methicillin sensitive Staph. aureus, methicillin sensitive Staph. epidermidis, Streptococcus Group B, Streptococcus group G, Strep. pyogenes, Strep. viridans, Streptococcus sp. (excluding Enterococci), Peptostreptococcus sp., E. coli, E. cloacae, Klebsiella sp. (including K. pneumoniae and K. oxytoca), P. mirabilis, M. morganii and S. marcescens.,3 Urinary tract infections (complicated and uncomplicated). Caused by E. coli, P. mirabilis, P. vulgaris, M. morganii and Klebsiella sp. (including K. pneumoniea).,4 Uncomplicated gonorrhoea (cervical/urethral and rectal). Caused by N. gonorrhoeae, including both penicillinase and nonpenicillinase producing strains.,5 Bacterial septicaemia. Caused by Strep. pneumoniae, E. coli and H. influenzae.,6 Bone infections. Caused by methicillin sensitive Staph. aureus, methicillin sensitive Staph. epidermidis, Streptococcus group B, Strep. pneumoniae, Streptococcus sp. (excluding Enterocci), E. coli, Enterobacter sp., P. mirabilis and K. pneumoniae.,7 Joint infections. Caused by methicillin sensitive Staph. aureus, Strep. pneumoniae, Streptococcus sp. (excluding Enterococci), E. coli, P. mirabilis, K. pneumoniae and Enterobacter sp.,8 Menigitis. the initial treatment, as a single agent, of menigitis in children and immunocompetent adults when presumed or proven to be caused by H. influenzae type b, N. menigitidis, Strep. pneumoniae or Enterobacteriaceae pending culture and sensitivity results.,9 Surgical prophylaxis. The preoperative administration of a single 1g dose of ceftriaxone may reduce the incidence of postoperative infections in patients undergoing vaginal or abdominal hysterectomy or cholecystectomy in high risk patients, surgical procedures which are classified as contaminated or potentially contaminated, and patients undergoing coronary artery bypass surgery. Although ceftriaxone has been shown to have been as effective as cefazolin in the prevention of infection following coronary artery bypass surgery, no placebo controlled trials have been conducted.,10 Susceptibility testing. Before instituting treatment with ceftriaxone, appropriate specimens should be obtained for isolation of the causative organism and for determination of its susceptibility to the drug. Therapy may be instituted prior to obtaining results of susceptibility testing.
Source: ARTG
Storage conditions
- Shelf lifetime is 24 Months
- Store below 25 degrees Celsius
- Protect from Light; Protect from Moisture
Source: ARTG
How to use this medicine
Non-composite pack
This medicine contains one component only.
Component
- Injection, powder for
- Intramuscular
- Almost white or yellowish, slightly hygroscopic, crystalline powder
Source: ARTG
Do I need a prescription?
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4: Prescription Only Medicine.
- 1 vial, 5 vials, 10 vials
Source: ARTG
Is this medicine subsidised?
This medicine is not listed on the Pharmaceutical Benefits Scheme (PBS). Talk to your pharmacist about how much it will cost.
Source: PBS
Pregnant or planning a pregnancy?
For the active ingredient: Ceftriaxone
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Source: AHT
Reporting side effects
If you experience a side effect from this medicine, tell your doctor or pharmacist. Or report it directly to the TGA (Therapeutic Goods Administration).
You can report side effects to your doctor, or directly at Report an adverse event or safety problem (Opens in new tab)
Source: ARTG
Data sources
- Australian Health Thesaurus (AHT) (Opens in new tab) – Last updated on 3 August 2026
- Australian Medicines Terminology (AMT) (Opens in new tab) – Last updated on 3 August 2026
- Australian Register of Therapeutic Goods (ARTG) (Opens in new tab) – Last updated on 3 August 2026
- Pharmaceutical Benefits Scheme (PBS) (Opens in new tab) – Last updated on 3 August 2026
- Medicines Information Pty Ltd (Opens in new tab) – Last updated on 4 March 2026
Disclaimer
Healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions (Opens in new tab).
Symptom Checker
Worried about your health?
Select a symptom, answer some questions, get advice